Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.93 USD | +0.78% | +12.21% | +36.88% |
Financials (USD)
Sales 2024 * | 325K | Sales 2025 * | 7.46M | Capitalization | 130M |
---|---|---|---|---|---|
Net income 2024 * | -62M | Net income 2025 * | -60M | EV / Sales 2024 * | 401 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 17.4 x |
P/E ratio 2024 * |
-2.09
x | P/E ratio 2025 * |
-2.44
x | Employees | 58 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.42% |
Latest transcript on aTyr Pharma, Inc.
1 day | +0.78% | ||
1 week | +14.20% | ||
Current month | +22.93% | ||
1 month | +13.53% | ||
3 months | +0.26% | ||
6 months | +72.32% | ||
Current year | +36.88% |
Managers | Title | Age | Since |
---|---|---|---|
Sanjay Shukla
CEO | Chief Executive Officer | 52 | 16-03-29 |
Jill Broadfoot
DFI | Director of Finance/CFO | 63 | 18-07-29 |
Lisa Carey
CTO | Chief Tech/Sci/R&D Officer | - | 15-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Schimmel
FOU | Founder | 83 | 05-09-07 |
Tim Coughlin
CHM | Chairman | 57 | 17-04-09 |
John Clarke
BRD | Director/Board Member | 70 | 05-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 1.93 | +0.78% | 423,218 |
24-05-15 | 1.915 | +5.22% | 489,550 |
24-05-14 | 1.82 | +7.06% | 415,503 |
24-05-13 | 1.7 | +0.59% | 4,636,559 |
24-05-10 | 1.69 | -1.74% | 224,343 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.88% | 130M | |
+33.37% | 49.46B | |
+1.55% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+11.57% | 26.61B | |
-21.00% | 18.64B | |
+7.36% | 13.16B | |
+28.30% | 12.55B | |
+23.80% | 12.1B |
- Stock Market
- Equities
- LIFE Stock